Wiley.com

User login

Press Releases

  • March 24, 2017
    Carbapenems are among the "antibiotics of last resort" and can fight infections for which other drugs have long lost their effectiveness. However, even carbapenem-resistant pathogenic strains have emerged over the last decades. To find out whether a pathogen contains carbapenem-cleaving enzymes, the carbapenemases, Chinese scientists have developed a simple and fast assay based on a fluorescent probe and optical detection. They introduce their approach in the journal Angewandte Chemie ....
  • March 24, 2017
    A special kind of small sulfur-rich proteins, the metallothioneins, have an extraordinarily large capability for binding heavy metals. An international team of scientists has now discovered that the marine common periwinkle, which is widely considered a delicacy, contains the largest version of the protein found yet, with one additional cadmium-binding domain and a one-third higher detoxification capacity. As they report in the journal Angewandte Chemie, this feature may help the snail survive...
  • March 23, 2017
    HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons, Inc. (NYSE:JWA) (NYSE:JWB), a global research and learning company, announced that the Board of Directors has declared a quarterly cash dividend of $0.31 per share on its Class A and Class B Common Stock, payable on April 19, 2017 to shareholders of record on April 4, 2017. In June 2016, the Board of Directors increased Wiley’s quarterly cash dividend by 3.3% to $0.31 per share on its Class A and Class B...
  • March 22, 2017
    HOBOKEN, N.J.--(BUSINESS WIRE)--John Wiley & Sons, Inc., (NYSE:JWA) (NYSE:JWB) today announced the appointment of David C. Dobson, Chief Executive Officer at Digital River, to its Board of Directors, effective March 22, 2017. With more than 30 years of experience, David Dobson is an accomplished leader. Dobson joined Digital River in February 2013 as the company’s Chief Executive Officer. Dobson leads Digital River in its mission to help companies find...
  • March 22, 2017
    In a study of adults aged 40 to 90 years who were followed for 10 years, poor smell was linked with an increased risk of dying.During the study, 411 of 1774 participants (23%) died. After controlling for demographic, health-related, and cognitive confounders, each additional correctly identified odor lowered the risk of mortality by 8%. Individuals who performed at chance level on tests (indicating complete olfactory loss) were at a 19% higher risk of death than individuals with normal smell...
  • March 22, 2017
    A large prospective study in 309 adolescent boys and girls underscores the importance of physical activity for developing bone strength during growth. Adolescents who participated in moderate to intense physical activity during growth spurt years exhibited greater bone mass in areas that contribute to superior bone strength. The study also found mixed effects of sedentary time. Additional studies are needed to determine the right balance between physical activity and recovery time to...
  • March 22, 2017
    In the largest German survey on heart failure to date, investigators found that the overall awareness of heart failure has not increased over the past decade and is not at a satisfactory level.   In 2007, 2012, and 2015, respectively, 2531, 359, and 171 adults answered questions about causes, presentation, prognosis, and treatment of heart failure. In 2007, 68% percent of respondents knew that heart failure was weakness of the heart. Regarding the three major symptoms of heart failure, 79...
  • March 22, 2017
    A new study has examined whether different blood thinning medications prescribed to prevent strokes in patients with atrial fibrillation might increase the risk of heart attacks.In the retrospective study of 30,146 patients, investigators found a twofold increased risk in patients taking direct acting oral anticoagulants (dabigatran and rivaroxaban) compared with those taking vitamin k antagonists such as warfarin. Heart attack risk was also higher in patients taking aspirin than in those...
  • March 22, 2017
    A new review addresses the mysteries behind “good” HDL cholesterol and why boosting its levels does not necessarily provide protection from cardiovascular risk for patients. It appears that augmenting the function of HDL cholesterol, rather than its concentration, is key.The review details the manner in which tissue and systemic inflammation affects the metabolism of HDL cholesterol via several pathways, pointing to ways to improve its production and function. “Our own clinical studies as...
  • March 22, 2017
    A new study challenges the widely accepted but oversimplified description of airway inflammation in smokers and patients with chronic obstructive pulmonary disease (COPD).   By analyzing airway wall tissue from individuals, investigators found that there are significantly fewer cells in the airway wall of smokers and mild to moderate COPD patients than in healthy controls, with a surprising decrease in some key inflammatory cells.   “Airway inflammation in COPD is a true paradox,”...